Soligenix
SNGX
#10972
Rank
NZ$14.1 M
Marketcap
NZ$0.65
Share price
4.90%
Change (1 day)
-77.93%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2026 (TTM): -NZ$20.01 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$21.11 Million a decrease over its 2024 earnings that were of -NZ$16.66 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$20.01 Million-5.25%
2025 -NZ$21.11 Million26.72%
2024 -NZ$16.66 Million22.96%
2023 -NZ$13.55 Million-45.74%
2022 -NZ$24.97 Million11.88%
2021 -NZ$22.32 Million-32.37%
2020 -NZ$33 Million83.18%
2019 -NZ$18.02 Million11.57%
2018 -NZ$16.15 Million19.29%
2017 -NZ$13.54 Million33%
2016 -NZ$10.18 Million-19.7%
2015 -NZ$12.67 Million5.16%
2014 -NZ$12.05 Million
2010 -NZ$13.6 Million26.12%
2009 -NZ$10.79 Million75.1%
2008 -NZ$6.16 Million-45.38%
2007 -NZ$11.28 Million-22.84%
2006 -NZ$14.62 Million66.15%
2005 -NZ$8.8 Million-16.65%
2004 -NZ$10.56 Million13.28%
2003 -NZ$9.32 Million-11.88%
2002 -NZ$10.57 Million-59.44%
2001 -NZ$26.07 Million378.18%
2000 -NZ$5.45 Million-38.53%
1999 -NZ$8.87 Million-18.43%
1998 -NZ$10.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$46.70 B-224,027.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$12.30 B-59,115.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$12.75 B-61,279.19%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-NZ$32.36 Million 55.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-NZ$74.42 Million 256.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.85 B-13,813.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-NZ$4.91 Million-76.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-NZ$0.17 Billion 712.56%๐Ÿ‡บ๐Ÿ‡ธ USA